These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 5113081)
21. [Diabetic retinitis and its medical treatment]. Journ Annu Diabetol Hotel Dieu; 1967; 7():417-9. PubMed ID: 6058568 [No Abstract] [Full Text] [Related]
22. [Value of tetrahydroxy flavan-diol in ophthalmology, especially in chronic retinopathy (40 cases)]. Magnard G; Franck JP; Dorne PA Lyon Med; 1970 Jan; 223(4):259-63. PubMed ID: 5435320 [No Abstract] [Full Text] [Related]
24. [The action of calcium dobesilate in diabetic retinopathy]. Sevin R; Cuendet JF Bull Mem Soc Fr Ophtalmol; 1969; 82():170-80. PubMed ID: 5402400 [No Abstract] [Full Text] [Related]
25. Prospects for angiotensin receptor blockers in diabetic retinopathy. Sjølie AK Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S31-9. PubMed ID: 17321627 [TBL] [Abstract][Full Text] [Related]
26. [How can we classify diabetic retinopathy? Does medical treatment exist?]. Rousselie F; Haut J Journ Annu Diabetol Hotel Dieu; 1977; ():297-306. PubMed ID: 894871 [No Abstract] [Full Text] [Related]
29. [Treatment of diabetic retinopathy with adrenal cortex hormones and anabolic agents]. Merlin U G Veneto Sci Med; 1965; 20(3):129-37. PubMed ID: 5839485 [No Abstract] [Full Text] [Related]
30. [Our experience with complex drug therapy of diabetic retinopathy]. Rogozina RD Oftalmol Zh; 1974; 29(7):540-2. PubMed ID: 4437871 [No Abstract] [Full Text] [Related]
31. [Treatment of diabetic angiopathies of the lower extremities]. Genyk SN; Kozan' IV Vestn Khir Im I I Grek; 1983 Jun; 130(6):144-7. PubMed ID: 6351405 [No Abstract] [Full Text] [Related]
32. [Diabtyl]. Journ Annu Diabetol Hotel Dieu; 1971 May; 12(0):281-3. PubMed ID: 5164735 [No Abstract] [Full Text] [Related]
34. [Diabetic retinopathy]. Zygulska-Mach H; Bryk E Folia Med Cracov; 1981; 23(1):47-66. PubMed ID: 6178658 [No Abstract] [Full Text] [Related]
35. [Immune and microcirculatory disorders in patients with diabetic retinopathy and their correction]. Petrunia AM Vestn Oftalmol; 1996; 112(1):43-6. PubMed ID: 8659072 [TBL] [Abstract][Full Text] [Related]
36. Medical treatment of diabetic retinopathy. Donaldson M; Dodson PM Eye (Lond); 2003 Jul; 17(5):550-62. PubMed ID: 12855958 [No Abstract] [Full Text] [Related]
37. Growth factors and protein kinase C inhibitors as novel therapies for the medical management diabetic retinopathy. Aiello LP; Cahill MT; Cavallerano JD Eye (Lond); 2004 Feb; 18(2):117-25. PubMed ID: 14762400 [TBL] [Abstract][Full Text] [Related]
38. Pharmacological approach to diabetic retinopathy. De La Cruz JP; González-Correa JA; Guerrero A; de la Cuesta FS Diabetes Metab Res Rev; 2004; 20(2):91-113. PubMed ID: 15037985 [TBL] [Abstract][Full Text] [Related]
39. [Growth factors in proliferative diabetic retinopathy]. Ioniţă M Oftalmologia; 1997; 41(3):193-6. PubMed ID: 9409959 [TBL] [Abstract][Full Text] [Related]